首页 | 本学科首页   官方微博 | 高级检索  
     


Evaluation of Cancer Dependence and Druggability of PRP4 Kinase Using Cellular,Biochemical, and Structural Approaches
Authors:Qiang Gao  Ingrid Mechin  Nayantara Kothari  Zhuyan Guo  Gejing Deng  Kimberly Haas  Jessica McManus  Dietmar Hoffmann  Anlai Wang  Dmitri Wiederschain  Jennifer Rocnik  Werngard Czechtizky  Xin Chen  Larry McLean  Heike Arlt  David Harper  Feng Liu  Tahir Majid  Vinod Patel  Christoph Lengauer  Carlos Garcia-Echeverria  Bailin Zhang  Hong Cheng  Marion Dorsch  Shih-Min A. Huang
Abstract:PRP4 kinase is known for its roles in regulating pre-mRNA splicing and beyond. Therefore, a wider spectrum of PRP4 kinase substrates could be expected. The role of PRP4 kinase in cancer is also yet to be fully elucidated. Attaining specific and potent PRP4 inhibitors would greatly facilitate the study of PRP4 biological function and its validation as a credible cancer target. In this report, we verified the requirement of enzymatic activity of PRP4 in regulating cancer cell growth and identified an array of potential novel substrates through orthogonal proteomics approaches. The ensuing effort in structural biology unveiled for the first time unique features of PRP4 kinase domain and its potential mode of interaction with a low molecular weight inhibitor. These results provide new and important information for further exploration of PRP4 kinase function in cancer.
Keywords:Cancer Therapy   Crystallography   Drug Discovery   Proteomics   Structural Biology
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号